Amwell Announces Results for Second Quarter 2024
Amwell (NYSE: AMWL), a small-cap growth healthcare company specializing in healthcare software as a service, has released its financial results for the second quarter of 2024, ending June 30. The company has made the detailed earnings report available on its investor relations website. Amwell will host a conference call on July 31, 2024, at 5 p.m. ET to discuss the financial results. Interested parties can access the call via a live audio webcast or by dialing in, with separate numbers provided for U.S. and international participants. A replay of the call will be available on the company's website after the event concludes.
Amwell (NYSE: AMWL), una compagnia di healthcare in crescita a bassa capitalizzazione specializzata nel software sanitario come servizio, ha pubblicato i risultati finanziari per il secondo trimestre del 2024, terminato il 30 giugno. L'azienda ha reso disponibile il rapporto dettagliato sugli utili sul suo sito web per le relazioni con gli investitori. Amwell terrà una conferenza telefonica il 31 luglio 2024, alle 17:00 ET per discutere i risultati finanziari. Le parti interessate possono partecipare alla chiamata tramite webcast audio in diretta o chiamando, con numeri separati forniti per i partecipanti statunitensi e internazionali. Una registrazione della chiamata sarà disponibile sul sito web della compagnia dopo il termine dell'evento.
Amwell (NYSE: AMWL), una empresa de atención médica de pequeña capitalización en crecimiento que se especializa en software de atención médica como servicio, ha publicado sus resultados financieros para el segundo trimestre de 2024, que finalizó el 30 de junio. La compañía ha puesto a disposición el informe detallado de ganancias en su sitio web de relaciones con inversores. Amwell llevará a cabo una conferencia telefónica el 31 de julio de 2024, a las 5 p.m. ET para discutir los resultados financieros. Las partes interesadas pueden acceder a la llamada a través de una transmisión de audio en vivo o marcando, con números separados proporcionados para participantes de EE.UU. e internacionales. Una grabación de la llamada estará disponible en el sitio web de la compañía después de que concluya el evento.
Amwell (NYSE: AMWL)는 헬스케어 소프트웨어를 서비스로 전문으로 하는 중소형 성장 헬스케어 회사로, 2024년 2분기 재무 결과를 6월 30일 기준으로 발표했습니다. 회사는 투자자 관계 웹사이트에 상세한 수익 보고서를 공개했습니다. Amwell은 2024년 7월 31일 오후 5시 ET에 재무 결과를 논의하기 위해 컨퍼런스 콜을 개최할 예정입니다. 관심 있는 당사자는 라이브 오디오 웹캐스트를 통해 또는 별도로 제공된 미국 및 국제 참여자를 위한 전화번호로 참여할 수 있습니다. 이벤트 종료 후에는 회사 웹사이트에서 전화 통화의 재생이 가능합니다.
Amwell (NYSE: AMWL), une entreprise de soins de santé à petite capitalisation spécialisée dans les logiciels de soins de santé en tant que service, a publié ses résultats financiers pour le deuxième trimestre de 2024, se terminant le 30 juin. L'entreprise a rendu le rapport détaillé des bénéfices disponible sur son site Web de relations investisseurs. Amwell organisera une conférence téléphonique le 31 juillet 2024 à 17h00 ET pour discuter des résultats financiers. Les parties intéressées peuvent accéder à l'appel via un webinaire audio en direct ou en composant un numéro de téléphone, des numéros séparés étant fournis pour les participants américains et internationaux. Un enregistrement de l'appel sera disponible sur le site Web de la société après l'événement.
Amwell (NYSE: AMWL), ein wachsendes Unternehmen im Gesundheitssektor mit kleiner Marktkapitalisierung, das sich auf Gesundheitssoftware als Dienstleistung spezialisiert hat, hat seine finanziellen Ergebnisse für das zweite Quartal 2024, das am 30. Juni endete, veröffentlicht. Das Unternehmen hat den detaillierten Bericht über die Gewinne auf seiner Investor-Relations-Website bereitgestellt. Amwell wird am 31. Juli 2024 um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die finanziellen Ergebnisse zu besprechen. Interessierte Parteien können die Konferenz über ein Live-Audio-Webcast oder durch Einwahl teilnehmen, wobei separate Nummern für Teilnehmer aus den USA und international bereitgestellt werden. Eine Aufzeichnung des Anrufs wird nach der Veranstaltung auf der Website des Unternehmens verfügbar sein.
- None.
- None.
Boston, July 31, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell’s investor relations website at investors.amwell.com to view the second quarter 2024 earnings report.
The company will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, July 31. The call can be accessed via a live audio webcast at investors.amwell.com or by dialing 1-888-510-2008 for U.S. participants or 1-646-960-0306 for international participants, referencing conference ID number 7830032. A replay of the call will be available via webcast shortly after the completion of the call, at the same web link.
About Amwell
Amwell is a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.
©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.
FAQ
When did Amwell (AMWL) release its Q2 2024 financial results?
How can investors access Amwell's (AMWL) Q2 2024 earnings report?
When is Amwell (AMWL) hosting its Q2 2024 earnings conference call?
How can investors participate in Amwell's (AMWL) Q2 2024 earnings call?
